Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer

被引：2
|
作者：
Shobab, Leila [1 ]
Wartofsky, Leonard [2 ]
机构：
[1] MedStar Washington Hosp Ctr, 110 Irving St NW,Room 2A72, Washington, DC 20010 USA
[2] MedStar Hlth Res Inst, Washington, DC USA
来源：
THYROID | 2023年 / 33卷 / 02期
关键词：
TERT PROMOTER MUTATIONS; DISTANT METASTASES; PAPILLARY; BRAF; ASSOCIATION; CARCINOMA; MED12; POLYMORPHISMS; BRAF(V600E); GENES;
D O I：
10.1089/thy.2022.0428
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：138 / 142
页数：5
相关论文
共 50 条
  • [11] Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
    Liu, Jierui
    Liu, Yanqing
    Lin, Yansong
    Liang, Jun
    ENDOCRINOLOGY AND METABOLISM, 2019, 34 (03) : 215 - 225
  • [12] Poorly differentiated thyroid cancer
    Patel, Kepal N.
    Shaha, Ashok R.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2014, 22 (02): : 121 - 126
  • [13] Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
    Zhang, Lu
    Li, Zhi
    Zhang, Meng
    Zou, Huangren
    Bai, Yuke
    Liu, Yanlin
    Lv, Juan
    Lv, Ling
    Liu, Pengjie
    Deng, Zhiyong
    Liu, Chao
    MEDICAL ONCOLOGY, 2023, 40 (09)
  • [14] Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
    Lu Zhang
    Zhi Li
    Meng Zhang
    Huangren Zou
    Yuke Bai
    Yanlin Liu
    Juan Lv
    Ling Lv
    Pengjie Liu
    Zhiyong Deng
    Chao Liu
    Medical Oncology, 40
  • [15] Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer
    Capdevila, Jaume
    Newbold, Kate
    Licitra, Lisa
    Popovtzer, Axon
    Moreso, Francesc
    Zamorano, Jose
    Kreissl, Michael
    Aller, Javier
    Grande, Enrique
    CANCER TREATMENT REVIEWS, 2018, 69 : 164 - 176
  • [16] EVOLVING APPROACHES IN MANAGING RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
    Sacks, Wendy
    Braunstein, Glenn D.
    ENDOCRINE PRACTICE, 2014, 20 (03) : 263 - 275
  • [17] Challenges in the evaluation and management of radioactive iodine-refractory differentiated thyroid cancer
    Genco, Matthew T.
    Yaqub, Abid
    Jana, Suman
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (07) : 743 - 745
  • [18] Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
    Schmidt, Angelica
    Iglesias, Laura
    Klain, Michele
    Pitoia, Fabian
    Schlumberger, Martin J.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (01): : 81 - 89
  • [19] Update on the systemic management of radioactive iodine refractory differentiated thyroid cancer (Review)
    Babu, Geethu
    Kainickal, Cessal Thommachan
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (02) : 1 - 7
  • [20] Is Poorly Differentiated Thyroid Cancer Poorly Characterized?
    Burman, Kenneth D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (04): : 1167 - 1169
12345